Randomized Trial of Biolimus DCB for In-Stent RestenosisRobert A. Byrne, Fernándo Alfonso, Himanshu Rai et al.|JACC: Cardiovascular Interventions|2025Cited by 21
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)Robert A. Byrne, Seán Fitzgerald, Fernándo Alfonso et al.|Cardiovascular revascularization medicine|2023Cited by 17
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority TrialChristian Spaulding, Maurizio d’Amico, Florian Krackhardt et al.|Circulation|2026Cited by 5
9 A prospective, randomized, non-inferiority trial to determine the safety and efficacy of the biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: first-in-man trial (REFORM)Seán Fitzgerald, RA Byrne, BP Traynor et al.|Unknown|2023Cited by 1
37 You want my advice and guidance? performance of a cardiology email advice line to general practitionersJohn Belsham, Helen Routledge, David G. Wilson et al.|Unknown|2019Cited by 0